Liquidia Corporation Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for LQDA, updated each market day.
LQDA AI Sentiment
AI predicts Liquidia Corporation Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Liquidia Corporation Common Stock
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Sector
Exchange
Market Cap
$3,300,766,510
Cap Tier
Employees
216
Headquarters
MORRISVILLE, NC
Listed Since
July 26, 2018
Website
LQDA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LQDA Volatility
Liquidia Corporation Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
